Alunbrig Tablets 30mg, with the ingredient Brigatinib, are produced by Takeda Pharmaceutical. This medication (YJ code: 4291069F1022, 30mg 1 tablet) is a kinase inhibitor indicated for the treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).
Alunbrig Tablets 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →